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Staphylococcus aureus capsular polysaccharides (CP) are important virulence factors and represent putative targets for vaccine devel-
opment. Therefore, the purpose of this studywas to develop a high-throughputmethod to identify and discriminate the clinically im-
portant S. aureus capsular serotypes 5, 8, andNT (nontypeable). A comprehensive set of clinical isolates derived fromdifferent origins
and control strains, representative for each serotype, were used to establish aCP typing systembased onFourier transform infrared
(FTIR) spectroscopy and chemometric techniques. By combining FTIR spectroscopywith artificial neuronal network (ANN) analysis,
a systemwas successfully established, allowing a rapid identification anddiscrimination of all three serotypes. The overall accuracy of
theANN-assisted FTIR spectroscopyCP typing systemwas 96.7% for the internal validation and 98.2% for the external validation.One
isolate in the internal validation and one isolate in the external validation failed in the classification procedure, but none of the isolates
was incorrectly classified. The present study demonstrates that ANN-assisted FTIR spectroscopy allows a rapid and reliable discrimina-
tion of S. aureus capsular serotypes. It is suitable for diagnostic as well as large-scale epidemiologic surveillance of S. aureus capsule
expression andprovides useful informationwith respect to chronicity of infection.
Staphylococcus aureus capsular polysaccharide (CP) expressionis known to be an essential cell surface-associated virulence
factor that exhibits immunogenic properties. It protects the bac-
teria fromphagocytic clearance and augmentsmicrobial virulence
(1, 2). Although various S. aureus CP serotypes have been de-
scribed during the last 3 decades, prototype strains and antisera
are available only for serotypes 1 (CP1), 2 (CP2), 5 (CP5), and 8
(CP8) (3, 4). The heavily encapsulated CP1 and CP2 strains are
very rare among clinical isolates, and their mucoid colonies are
easily recognized on solid medium. Most human S. aureus strains
express either a CP5 or CP8 polysaccharide capsule. Therefore,
CP5- and CP8-specific antibodies are routinely used for S. aureus
capsular serotyping. However, approximately 8% to 30% of hu-
man isolates (5–9) and up to 86% of bovine isolates (10) do not
express either CP5 or CP8, although almost all of them carry the
respective genes coding for CP5 or CP8 (4). S. aureus isolates that
do not react with antibodies to serotype CP5 and CP8 and do not
produce mucoid colonies on solid agar medium (CP1 and CP2)
are subsumed under the term “nontypeable” (NT) (4, 11). Inter-
estingly, almost all NT isolates seem to react with surface antigen
336-specific antibodies (12, 13). Originally, antigen 336 was pro-
posed to be a capsular polysaccharide, but meanwhile, it has been
shown that antigen 336 is a poly(ribitol phosphate)-N-acetylglu-
cosamine-containing polymer, resembling cell wall teichoic acid
rather than capsule polysaccharides (14, 15). The prevalence of
nonencapsulated NT strains was found to be higher in chronic
than in acute infections (10, 11, 16, 17). The potential increase of
S. aureus infections caused by NT serotypes is therefore of special
concern. Continuous monitoring of changes in CP serotype prev-
alence and loss of CP expression is of utmost importance for epi-
demiological studies as well as for the development of future vac-
cines (12, 18).
Currently, the gold standard for S. aureus capsule serotyping is
the double immunodiffusion assay, in which capsular extracts re-
act against CP5- or CP8-specific antibodies (19). Alternative
methods, such as colony immunoblotting or enzyme-linked im-
munosorbent assay inhibition, are less sensitive but allow process-
ing of multiple samples in a shorter period of time (20, 21). How-
ever, the implementation of these immunoassays is limited to a
small number of laboratories. All of them are based on the avail-
ability of CP5- and CP8-specific antibodies, which are not com-
mercially available and require access to appropriate S. aureus
strains for immunization and animal experiments. In addition,
these methods are rather complex to perform and require specif-
ically trained personal. Novel suitable methods for CP serotyping
to be implemented in routine diagnostics as well as for epidemio-
logical purposes, requiring high-throughput capacities, are ur-
gently needed.
Metabolic fingerprinting by Fourier transform infrared (FTIR)
spectroscopy represents an interesting alternative for a rapid and
cost-effective discrimination of S. aureus capsular serotypes. FTIR
spectroscopy coupled to chemometric analysis has been widely
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used for identification, classification, and epidemiological typing
of numerous clinic- and food-derived pathogenic microorgan-
isms (22–26). Subspecies differentiation is probably the most
promising aspect of FTIR spectroscopy, as it is capable of moni-
toring conformational, compositional, and quantitative differ-
ences of biochemical compounds in microbial cells. The meta-
bolic fingerprints generated by FTIR spectroscopy reflect the
balance of all these factors based on inherent strain-specific differ-
ences of the genetic and phenotypic background. For instance,
FTIR spectroscopy has been successfully employed to differentiate
serotypes of Escherichia coli (27), Salmonella enterica (28), Listeria
monocytogenes (29), and Yersinia enterocolitica (30). The current
study aimed to decipher the potential of FTIR spectroscopy for dif-
ferential diagnostics of the most clinically relevant S. aureus capsular
polysaccharide types, namely, CP5, CP8, and the NT variants.
MATERIALS AND METHODS
Bacterial strains and culture conditions. A panel of 84 S. aureus strains
isolated from diverse clinical settings was compiled for this study (Table
1). Fifty-three of the isolates were derived from humans, whereas 31 had
animal origin. S. aureus Reynolds prototype strain CP5 and its isogenic
mutants Reynolds CP8 and Reynolds CP (nonencapsulated) (31) were
used as controls for geno- and serotyping as well as for FTIR spectroscopic
biotyping. S. aureus was propagated on Columbia agar (Difco) supple-
mented with 2% NaCl for 24 h at 37°C for the preparation of the capsule
extract used for the determination of theCP expression by immunoassays.
To assess the culture conditions that permit the highest discrimination
power between the different S. aureus CP types by means of FTIR spec-
troscopy, the following conditions were tested: (i) tryptone soy agar (TSA;
Oxoid) at 30°C for 24 h, (ii) TSA at 37°C for 24 h, (iii) TSA supplemented
with 2%NaCl at 37°C for 24 h, and (iv) Columbia base agar supplemented
with 2% NaCl at 37°C for 24 h. NaCl was added because it is known to
enhance CP production (32, 33). For all subsequent FTIR spectroscopic
biotyping experiments (including the measurement of the capsule ex-
tracts) and establishment of the ANN-assisted FTIR spectroscopic typing
system, bacterial strains were cultured on TSA plates for 24 h at 30°C.
Capsule extracts. Capsule extracts from S. aureus isolates were pre-
pared as previously described (34). Briefly, the complete bacterial lawn
from one 9-cm-diameter agar plate was harvested using 1 ml of 10 mM
phosphate-buffered saline (PBS) (0.15 M NaCl, pH 7.2) and the cell sus-
pensions were subsequently autoclaved for 1 h at 121°C. Bacteria were
pelleted by centrifugation at 10,000 g. The supernatants containing the
crude capsule extract were passed through 0.45-m filters and subjected
directly to FTIR spectroscopic analysis, used for CP type-specific antibody
production, or utilized for a double immunodiffusion assay.
Immune-based detection of CP expression. The CP serotype of the
isolates was determined by a colony immunoblotting assay using antibod-
ies specific for CP5 and CP8 (34). CP5 and CP8 antibodies were produced
by immunization of rabbits with killed encapsulated bacteria as described
previously (34), followed by absorption of the sera with unencapsulated
mutant strains to render it specific to either CP5 or CP8. Preimmune
rabbit serum and absorbed sera were nonreactive by immunodiffusion
against bacterial extracts containing CP5 and CP8. Isolates that were non-
reactive in the colony immunoblot assay were confirmed to be NT by the
double immunodiffusion assay, using the capsule extracts as previously
described (35). Briefly, a 1% agarose gel was prepared on a glass slide and
wells were punched in a circular fashion around a central hole. Absorbed
CP5 and CP8 antiserumwas added to the central well, and serial dilutions
of bacterial extracts were applied to the outer wells (20). Immunodiffu-
sion was conducted in a moist chamber at room temperature. After 24 h,
the precipitin lines formed were visualized by Coomassie brilliant blue
staining. CP extracts from Reynolds CP5, Reynolds CP8, and Reynolds
CP strains were used as positive and negative controls.
cap gene determination. The presence of the cap genes that define the
CP5 and CP8 serotypes was determined by PCR amplification using the
primers and conditions described elsewhere (15, 17). S. aureus Reynolds
CP5, Reynolds CP8, and Becker (CP8) were used as controls.
Sample preparation for FTIR spectroscopy. For whole-cell FTIR
spectroscopy, bacteria were grown as lawn on TSA agar plates as indicated
above. One loopful of bacterial biomass was suspended in 100l of sterile
deionized water (36). An aliquot of 30l of the resulting bacterial suspen-
sion was spotted on a zinc selenite (ZnSe) optical plate (sample holder)
and dried at 40°C for 40 min to yield transparent films, which were used
directly for FTIR spectroscopy. For FTIR spectroscopy of capsule extracts,
30l of the crude capsule extracts was spotted on the sample holder, dried
at 40°C for 40 min, and subsequently measured as described below.
FTIR spectroscopic measurement and spectral preprocessing. FTIR
spectroscopywas conductedwith anHTS-XTmicroplate adapter coupled
to a Tensor 27 FTIR spectrometer (Bruker Optics GmbH, Ettlingen, Ger-
many). Infrared spectra were recorded in transmission mode in the spec-
tral range between 4,000 and 500 cm1. The OPUS software (version 6.5;
BrukerOpticsGmbH)was used to calculate 2nd derivatives of the original
spectra with a 9-point Savitzky-Golay filter to increase spectral resolution
and to minimize problems with baseline shifts. Subsequent vector nor-
malization was performed for the whole spectral range to adjust biomass
variations among different sample preparations. As a measure of dissim-
ilarity, spectral distance values were calculated in the spectral range of
1,200 to 800 cm1 in order to determine the best growth conditions for
CP discrimination and to obtain the levels of reproducibility among the
10 replicates of each isolate used in the reference strain set (27).
Unsupervised multivariate statistics. The OPUS software was used
for hierarchical cluster analysis (HCA). Only the spectral region that of-
fers the maximum information and discriminatory power for character-
istic cellular macromolecules was examined. Normalized 2nd-derivative
spectra of the polysaccharide region (1,200 to 900 cm1) and partially of
the “fingerprint” region (900 to 800 cm1) were selected (22). Dendro-
grams were generated by using Ward’s algorithm with normalization to
repro level 30. For principal component analysis (PCA)—disregarding
groups—spectral data from these regions were exported to XLSTAT for
MS Excel (Addinsoft). By eigenvalue decomposition of a data covariance
(n) matrix, a set of correlated variables was reduced to two linear combi-
nations of these variables (principal components PC1 and PC2).
Artificial neuronal network analysis. To develop and to validate the
ANN for discrimination between CP5, CP8, and NT, the software Neu-
roDeveloper (version 2.5b; SynthonGmbH, Heidelberg, Germany) was
used (37). The collection of 87 S. aureus strains was subdivided into two
strain sets: 30 strains served as a reference data set (including Reynolds
control strains), and 57 strains were used for external validation. The
reference data set used to calibrate the model included 10 representative
isolates of each serotype, which were measured 10 times at different days
to cover the biological and technical variance. Spectra were randomly
divided into a training set, a prevalidation set, and a test set for internal
validation. The training set comprises eight out of the 10 recorded spectra,
and the test set and the validation set comprise one spectrum per strain
each. The strains used exclusively for external validation were measured
one time, simulating routine diagnostic procedures. Prior to the training
TABLE 1 S. aureus isolates used in this study
Capsule
serotype
No. of isolates:
Total
With each cap allele With each origin
cap5 cap8 None Human Animal Control
CP5 23 23 0 0 18 4 1
CP8 27 0 27 0 18 8 1
NT 37 24 11 2 17 19 1
Total 87 47 38 2 53 31 3
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process, spectral preprocessing and feature selection in the Feature-
Developer section of the software were performed according to the fol-
lowing parameters: 2nd-derivative spectral processing (Savitzky-Golay),
vector normalization, and feature selection in the spectral windows of
3,000 to 2,800 cm1 and 1,800 to 500 cm1 using the COVAR algorithm
to identify the 100most discriminative wavenumbers. In the NeuroSimu-
lator section, the Rprop algorithm was used and the training was stopped
when the validation error was at its minimum. By automatically changing
the numbers of input and hidden neurons, the ANN training was succes-
sively optimized until a correct classification result of90%of the spectra
for the internal validation was achieved. The classification procedure of
unknown samples is based on three analysis functions: WTA (winner
takes all), the 40-20-40 rule, and a potential extrapolation. To accept
classification, at least two of those three criteria have to be achieved (37).
Using a trained ANN model, results of measured spectra are finally clas-
sified as either (i) correct identification, (ii) incorrect identification, or
(iii) unknown classification.
RESULTS AND DISCUSSION
Selection of the strain set and optimization of growth condi-
tions for FTIR spectroscopic capsular biotyping. A comprehen-
sive set of strains, including human and veterinary clinical isolates,
was compiled (Table 1). All strains were initially serotyped by
colony immunoblot, and all NT isolates, showing no immunore-
activity against CP5 and CP8 antibodies, were additionally tested
by the more-sensitive double immunodiffusion assay. S. aureus
Reynolds CP5 and its isogenic mutants Reynolds CP8 and Reyn-
olds CPwere included as control strains for CP expression (31).
A reference strain set was defined, comprising a representative
selection of 10 isolates of each CP type (including the Reynolds
and its isogenic mutants). For all isolates, the genetic background
of the cap-specific allele was determined. cap allele determination
of NT isolates showing no CP expression revealed that they carry
either the cap allele cap5 or cap8 or none or both alleles. From the
37 NT isolates, 65% carried the cap5 allele and 30% carried the
cap8-specific allele. The remaining isolates (5%) did not show any
amplification products with the cap allele-specific primers (Table
1). NT isolates for the reference strain set were selected in such a
way that the different cap genetic backgrounds were well repre-
sented.
The control strains Reynolds CP5, CP8, and CPwere used to
determine the culture condition providing the highest discrimi-
natory power for differentiation of CP types by FTIR spectros-
copy. Strains were grown for 24 h under the following conditions:
(i) TSA at 30°C, (ii) TSA at 37°C, (iii) TSA supplemented with 2%
NaCl at 37°C, and (iv) Columbia base agar supplementedwith 2%
NaCl at 37°C. Bacteria were subsequently subjected to FTIR spec-
troscopic analysis (for details, seeMaterials andMethods). TSA at
30°C (condition i) was included since this culture condition is
routinely used for bacterial species identification by means of
FTIR spectroscopy (38) and has the advantage of allowing species
identification and CP biotyping of S. aureus strains using a single
FTIR spectrum, recorded only once. Columbia base agar supple-
mented with 2% NaCl at 37°C (condition iv) was included in the
set of tested cultivation conditions because it is well established for
immune-based capsule serotyping. Four independent experi-
ments were performed for each growth condition. PCA, an unsu-
pervised multivariate statistical method, was employed to investi-
gate the discriminatory features of the different growth conditions
for S. aureus capsule typing. The score plot for PC1 and PC2 re-
vealed a clear clustering of spectral data according to growth con-
ditions and S. aureusCP types, respectively. As shown in Fig. 1, all
growth conditions tested are suitable for discrimination of the
Reynolds CP5, CP8, and CP strains. However, the distance be-
tween the different strains dependedupon the chosen growth con-
ditions. The determination of spectral distance values, which are a
measure of dissimilarity corresponding to the nonoverlapping ar-
eas of the spectra, confirmed these findings: (i) TSA at 30°C, 0.55;
(ii) TSA at 37°C, 0.33; (iii) TSA supplemented with 2% NaCl at
37°C, 0.41; and (iv) Columbia base agar supplemented with 2%
NaCl at 37°C, 0.36. Hence, for FTIR spectroscopy-based CP de-
termination, TSA growth medium is superior to Columbia agar
base and a growth temperature of 30°C revealed a better resolu-
tion than 37°C. Overall, the best discrimination between the dif-
FIG 1 PCA was performed on 2nd-derivative and vector-normalized spectra in the spectral range of 1,200 to 800 cm1 recorded from the Reynolds CP5 strain
and its isogenic capsulemutants CP8 and CP grown at the following conditions: (i) TSA at 30°C and 24 h (red), (ii) TSA at 37°C and 24 h (green), (iii) TSA and
2%NaCl at 37°C and 24 h (yellow), and (iv) Columbia base and 2%NaCl at 37°C and 24 h (blue). PC1 was plotted against PC2. PC1 shows a distinct separation
of the different growth conditions, whereas PC2 discriminates the Reynolds CP5, CP8, and CP strains.
S. aureus Capsular Typing by FTIR Spectroscopy
July 2013 Volume 51 Number 7 jcm.asm.org 2263
ferent CP types was achieved for growth on TSA at 30°C (Fig. 1;
depicted in red), and these conditions were selected for develop-
ing the FTIR capsule serotyping system.
Reliable discrimination between encapsulated S. aureusCP5
and CP8 by FTIR spectroscopy using HCA. Hierarchical cluster
analysis (HCA) was employed to assess the overall similarity be-
tween isolates of the different CP serotypes. In order to extract
spectroscopically relevant information and to increase the dis-
criminatory power, the whole recorded spectral range of 4,000 to
500 cm1 was limited to 1,200 to 800 cm1. This spectral region
contains two blocks of relevant biochemical information: (i) 1,200
to 900 cm1, the polysaccharide region, and (ii) 900 to 800 cm1,
which forms part of the so-called “fingerprint” region (22). The
polysaccharide region is dominated by C-O-C andC-O-P stretch-
ing vibrations of polysaccharides and has been used previously to
discriminate the E. coli serotypes O:123 and O:4 (27) as well as for
the determination of L. monocytogenes serogroups (29). Several
spectral differences in this spectral region were also observed be-
tween CP5 and CP8 strains. Themost prominent differences were
located at 1,110 cm1, 1,097 cm1, 1,070 cm1, 1,058 cm1, 1,030
cm1, and 975 cm1 (data not shown). However, it is still unclear
which cellular components are responsible for the differences ob-
served.
A detailed manual analysis of the 2nd derivative of the re-
corded spectra from the different S. aureus strains revealed a
highly discriminatory spectral window in the “fingerprint” region,
not yet known to be suitable for serotyping. The spectral region of
845 to 810 cm1 especially showed remarkable differences be-
tween CP5 and CP8 strains (Fig. 2a). Specific spectral differences
between the two groups are found at 834 cm1 and 823 cm1. The
same spectral wavenumbers are also highly discriminatory for the
encapsulated Reynolds strain (CP5) and its isogenic mutant CP8
(Fig. 2b). In order to gain a better insight into this highly discrim-
inatory spectral region and to test if these differences can be as-
signed to CP, spectra of the crude polysaccharide capsule extract
from the Reynolds strain and its isogenic mutant CP8 were ana-
lyzed by FTIR spectroscopy (Fig. 2c) and compared with spectra
obtained from intact cells. Since the highest discriminatory power
for differentiation of the two serotypes was achieved for the cap-
sule extract, it can be assumed that themajor discriminatory com-
ponents in the spectral range of 845 to 810 cm1 for discrimina-
tion of CP5 and CP8 are related to capsule compounds.
Interestingly, it has been described that the spectral region at 860
to 825 cm1 is specific for an -anomeric configuration of carbo-
hydrates (39). An anomeric region absorption band located at 834
cm1 has been reported to be characteristic for -glycosidic link-
age of aldopyranoses in carbohydrates (40). Therefore, it is tempt-
ing to speculate that the highly discriminatory spectral band at 834
cm1 relates to different specific and structural -and -glyco-
sidic linkages in S. aureus capsules. And indeed, a specific -gly-
cosidic linkage type of the N-acetyl-D-fucosamine (D-FucNAc)
residues has been previously described for CP8 capsular polysac-
charides (41, 42) as follows: type 5,¡4)--D-ManNAcA-(1¡4)-
-L-FucNAc(3OAc)-(1¡3)--D-FucNAc-(1¡, and type 8,¡3)--
D-ManNAcA(4OAc)-(1¡3)--L-FucNAc-(1¡3)--D-FucNAc-(1¡.
As shown in the dendrogramdepicted in Fig. 3,HCAof the 2nd
FIG 2 FTIR spectra of S. aureus intact cells and capsule extracts in the spectral
range of 860 to 800 cm1, showing the discrimination between CP5 (solid line)
and CP8 (dashed line) at 834 cm1 and 823 cm1. All isolates were grown under
standardized conditions on TSA at 30°C for 24 h. (a) Clinical CP5 (n 10) and
CP8 (n 10) isolates included in the reference data set.Whole bacteria. (b) Reyn-
olds prototype strain CP5 and its isogenicmutant CP8.Whole bacteria. (c) Reyn-
olds prototype strain CP5 and its isogenicmutant CP8. Crude capsule extracts. (b
and c) Spectral data derived from three independent experiments. Each experi-
ment was performed in technical duplicates. A.U., arbitrary units.
FIG 3 FTIR spectroscopy-based dendrogram of the reference strain set, com-
prising 10 isolates from serotypes CP5, CP8, and NT. Second derivatives were
calculated from 10 replicate spectra of each isolate with a 9-point Savitzky-
Golay filter, and subsequent vector normalization was performed for the
whole spectral range. Dendrograms were obtained using Ward’s algorithm in
the spectral range of 1,200 to 800 cm1 at repro level 30.
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derivatives of FTIR spectral data obtained from the compiled S.
aureus strain set revealed two major clusters. Cluster A covers all
CP5 strains and cluster B covers all CP8 strains, while the NT
isolates are interspersed between the clusters. Subcluster A2 is
predominated by NT isolates with different cap gene allelic back-
grounds (NTcap5, -cap8, and -nt), but some NT isolates are clus-
tered to the CP5 subcluster A1 (one isolate of NTcap5) and to the
CP8 subcluster B2 (two isolates of NTcap8).
Based on their metabolic fingerprints, generated by FTIR spec-
troscopy, encapsulated CP5 and CP8 strains can be clearly dis-
criminated from each other. But these findings also show that
HCA alone is insufficient to discriminate between encapsulated
CP5/CP8 andnonencapsulatedNT isolates carrying the respective
cap5 or cap8 allele or none or both alleles. With respect to imple-
mentation in routine diagnostics, an artificial neural network
(ANN)-assistedmethodwould also simplify the readout of results
because data are clearly classified by the latter method (37).
Identification of S. aureus CP5, CP8, and NT using ANN-
assisted FTIR spectroscopy. It has been shown that the discrim-
inatory power of FTIR spectroscopy can significantly be improved
by combining it with appropriate chemometrics, especially by em-
ploying supervised learning methods, such as ANNs (see, for in-
stance, references 24, 30, and 43). We therefore used an ANN-
based approach to optimize our FTIR spectroscopic serotyping
system. To establish the ANNs, a panel of human and veterinary
clinical strains with known serotypes was compiled (for details,
see Materials and Methods). ANNs are simplified models of neu-
ral learning processes, which simulate the behavior of biological
neural nets. For the used feed-forward three-layer ANN, the in-
formation propagates from the input layer, through the hidden
layers, to the output layers. The ANN in our study was trained
with selected spectral signatures as input data (input neurons)
paired with the predefined output classes CP5, CP8, andNT (out-
put neurons). During the iterative training process, the connec-
tion weights (numbers of input and hidden neurons) are auto-
matically adjusted until the global error is minimized (44). In this
work, several single ANNs and consecutive combinations of
ANNs (modular ANNs) were tested to achieve an optimal net-
work performance. The ANN training resulted in a single-level
ANN using the 25 most discriminative wavenumbers (input neu-
rons), three hidden neurons, and three output neurons, one for
each CP type. For internal validation, one randomly selected spec-
trum of each isolate from the training set (n 30) was tested for
the correctness of the classification. For 29 out of 30 strains used
for the internal validation, a correct classification was achieved.
One strain yielded an uncertain result, but it was not incorrectly
classified. To assess the ANN performance, an external validation
was performed (Table 2). The external validation comprises only
isolates (n  57) which were not included in the training set to
develop the ANNmethod. To simulate routine diagnostic proce-
dures, strains were measured one time for the external validation.
In total, 98.2% (56/57) of the isolates were correctly identified.
One isolate was not able to be clearly assigned to one of the three
CP types (1.8%), but none of the isolates were incorrectly identi-
fied. In particular, the strain showing an unknown classification
was a nonencapsulated NT isolate.
In general, similar results for internal (96.7%) and external
(98.2%) validation of the ANN are a good indicator for the stabil-
ity of the established ANN model. It also indicates that a signifi-
cant part of the microbial diversity was covered by the selected
strain set (43). This underpins the reliability and robustness of the
established typing system.
CP serotyping is commonly performed in combination with
cap allele determination, requiring about 3 days for the immune-
based detection of CP expression. Usually, isolates are first sero-
typed by colony immunoblot (1 day) and NT isolates are subse-
quently confirmed by the double immunodiffusion assay (2 days).
FTIR spectroscopy-based capsule biotyping requires only 1 day
for growth of bacteria and less than 5 min of sample preparation
per strain. In addition, time and resources for animal experiments
for CP-specific antibody production are not needed and only a
minimum of bacterial biomass (about 108 bacteria) is required.
Since the sample preparation procedure is simple and data analy-
sis is automated by the software, no specific training is necessary.
Operating costs for FTIR spectroscopy are very lowbecause it does
not require specific reagents and ZnSe optical plates used for the
measurements are reusable. Overall, FTIR spectroscopy is, com-
pared to the current gold standard for CP serotyping by immune-
based detection, much faster, cheaper, and easier to perform. In
addition, due to its high-throughput capacities, it may also pro-
vide valuable epidemiological information about the chronicity of
specific S. aureus infections.
In conclusion, this study demonstrated that ANN-assisted
FTIR spectroscopy is a suitable tool for a rapid, cost-effective, and
reliable discrimination of S. aureus capsular serotypes CP5, CP8,
and NT. Since it is based on the metabolic fingerprint of the bac-
terium itself, it enables a routine high-throughput screening and
can be applied to monitor pathogen adaptation in host environ-
ments. Biotyping by FTIR spectroscopy therefore might not only
represent an interesting tool for clinical diagnostics but also may
contribute to the better understanding of the adaptation mecha-
nisms of S. aureus to the host, whichwould allow the development
of improved treatment regimes in the future, especially for
chronic infections.
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